277 related articles for article (PubMed ID: 26106205)
1. Diagnostic Utility of Biomarkers in COPD.
Ambade VN; Sontakke AN; Barthwal MS; Tyagi R; Basannar DR
Respir Care; 2015 Dec; 60(12):1729-42. PubMed ID: 26106205
[TBL] [Abstract][Full Text] [Related]
2. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K
Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in COPD patients, smokers, and non-smokers.
Tavilani H; Nadi E; Karimi J; Goodarzi MT
Respir Care; 2012 Dec; 57(12):2090-4. PubMed ID: 22710284
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
[TBL] [Abstract][Full Text] [Related]
6. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease.
Nadeem A; Raj HG; Chhabra SK
Inflammation; 2005 Feb; 29(1):23-32. PubMed ID: 16502343
[TBL] [Abstract][Full Text] [Related]
7. Anti-
Banerjee S; Bhattacharyya P; Mitra S; Kundu S; Panda S; Chatterjee IB
Int J Chron Obstruct Pulmon Dis; 2017; 12():1847-1856. PubMed ID: 28684907
[TBL] [Abstract][Full Text] [Related]
8. Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease.
Chang XY; Yang Y; Jia XQ; Wang Y; Peng LN; Ai XH; Jiang CY; Guo JH; Wu TT
Am J Med Sci; 2016 Mar; 351(3):244-52. PubMed ID: 26992252
[TBL] [Abstract][Full Text] [Related]
9. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
Di Stefano A; Coccini T; Roda E; Signorini C; Balbi B; Brunetti G; Ceriana P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1691-1700. PubMed ID: 29872287
[TBL] [Abstract][Full Text] [Related]
10. Specificity and sensitivity of the assay for elastin-derived peptides in chronic obstructive pulmonary disease.
Akers S; Kucich U; Swartz M; Rosen G; Glass M; Rosenbloom J; Kimbel P; Weinbaum G
Am Rev Respir Dis; 1992 May; 145(5):1077-81. PubMed ID: 1586050
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease (COPD).
Kurys E; Kurys P; Kuźniar A; Kieszko R
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():261-6. PubMed ID: 11977322
[TBL] [Abstract][Full Text] [Related]
12. MFG-E8, a clearance glycoprotein of apoptotic cells, as a new marker of disease severity in chronic obstructive pulmonary disease.
Zhang S; Xie JG; Su BT; Li JL; Hu N; Chen J; Luo GW; Cui TP
Braz J Med Biol Res; 2015 Nov; 48(11):1032-8. PubMed ID: 26375445
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress and altered levels of nitric oxide and peroxynitrite in Tunisian patients with chronic obstructive pulmonary disease: correlation with disease severity and airflow obstruction.
ben Anes A; Fetoui H; Bchir S; ben Nasr H; Chahdoura H; Chabchoub E; Yacoub S; Garrouch A; Benzarti M; Tabka Z; Chahed K
Biol Trace Elem Res; 2014 Oct; 161(1):20-31. PubMed ID: 25074430
[TBL] [Abstract][Full Text] [Related]
14. Serum oxidant/antioxidant status of patients with systemic lupus erythematosus.
Taysi S; Gul M; Sari RA; Akcay F; Bakan N
Clin Chem Lab Med; 2002 Jul; 40(7):684-8. PubMed ID: 12241014
[TBL] [Abstract][Full Text] [Related]
15. [The study of the antioxidant enzymes in erythrocytes in lung diseases].
Matskevich GN; Korotkina RN; Devlikanova ASh; Vishnevskiĭ AA; Karelin AA
Patol Fiziol Eksp Ter; 2003; (2):23-5. PubMed ID: 12838770
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease.
El-Deek SE; Makhlouf HA; Saleem TH; Mandour MA; Mohamed NA
Med Princ Pract; 2013; 22(5):469-74. PubMed ID: 23860258
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein D: a lung specific biomarker in COPD?
Sin DD; Pahlavan PS; Man SF
Ther Adv Respir Dis; 2008 Apr; 2(2):65-74. PubMed ID: 19124360
[TBL] [Abstract][Full Text] [Related]
18. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
19. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin polymorphism in relation to antioxidative enzymes activity in type 2 diabetes mellitus.
Awadallah SM; Ramadan AR; Nusier MK
Diabetes Metab Syndr; 2013; 7(1):26-31. PubMed ID: 23517792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
